About Cingulate, Inc. 
Cingulate, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 2 Schemes (3.48%)
Foreign Institutions
Held by 6 Foreign Institutions (0.84%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-9 Million
Pharmaceuticals & Biotechnology
USD 74 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.30
-847.60%
29.62






